Fagron Recalls SyrSpend SF Suspending Base Due to Microbial Contamination
Fagron, Inc. is recalling SyrSpend SF Suspending Base because the product was found to be contaminated with yeast and mold.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves microbial contamination with Aspergillus fumigatus, a pathogen capable of causing serious infections, particularly in immunocompromised individuals.
Plain-English summary
Fagron, Inc. is recalling SyrSpend SF Suspending Base, a prescription-only suspending base available in 500 mL and 4 L bottles. The recall involves 1,007 bottles of the 500 mL size and 738 bottles of the 4 L size. The affected products were distributed nationwide in the United States.
The recall was initiated due to microbial contamination. Testing revealed the presence of yeast and mold, specifically Paecilomyces saturatus and Aspergillus fumigatus. The agency has classified this as a Class II recall.
Consumers and healthcare providers should stop using the affected products and contact Fagron, Inc. or their healthcare provider for further instructions. The specific lot codes and expiration dates for the recalled items are listed in the official recall documentation.
The recalled product
- Product
- SyrSpend SF Suspending Base, a) 500 mL (NDC 51552-1079-5) and b) 4 L (NDC 51552-1079-9), Rx Only, Manufactured by Fagron Inc. St. Paul, MN 55120
- Manufacturer
- Fagron, Inc
- Category
- Drug — Pharmaceutical Excipient
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- a) 17I28-U80-039976
- exp. 10/02/2020
- b) 17I28-U80-039977
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Fagron, Inc
See all →- HighNystatin Bulk Powder Recall for Incorrect Label Assay Value
FDA (Drugs) · 2023-12-27
- HighNystatin Powder Recall Due to Incorrect Assay Strength on Label
FDA (Drugs) · 2023-12-27
- HighNystatin bulk powder recall due to incorrect assay strength label
FDA (Drugs) · 2023-12-27
- HighNystatin Bulk Powder Recalled Due to Incorrect Label Strength
FDA (Drugs) · 2023-12-27
- SevereSyrSpend SF Suspending Base Recalled for Burkholderia Contamination
FDA (Drugs) · 2022-05-18
Same hazard · microbial contamination
See all →- CriticalVictory Medical Center Pharmacy Recalls Glutathione Vials Due to Contamination
FDA (Drugs) · 2026-08-19
- HighMedline Medical Convenience Kits Recalled Due to Potential Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighMedline Convenience Kits Recalled Over Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15